Literature DB >> 10508263

Identification of a cross-reactive self ligand in virus-mediated autoimmunity.

T Ohteki1, A Hessel, M F Bachmann, A Zakarian, E Sebzda, M S Tsao, K McKall-Faienza, B Odermatt, P S Ohashi.   

Abstract

Molecular mimicry has been considered to be one of the potential mechanisms underlying the induction of autoimmune diseases. Using a TCR-transgenic model specific for lymphocytic choriomeningitis virus (LCMV) we have examined the potential for cross-reactive recognition of tissue-restricted self peptides. Several peptides were identified that were able to cross-react with the TCR-transgenic virus-specific T cells in vitro. One peptide was derived from dopamine beta-mono-oxygenase, an enzyme expressed in the adrenal medulla. Interestingly, after activation of the transgenic T cells with LCMV glycoprotein peptides or viruses, infiltration of the adrenal medulla was detected in conjunction with alterations in dopamine metabolism. However, complete destruction of the adrenal medulla was not observed. This suggests that molecular mimicry may be sufficient for self recognition and infiltration, but other factors clearly contribute to chronic autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508263     DOI: 10.1002/(SICI)1521-4141(199909)29:09<2886::AID-IMMU2886>3.0.CO;2-A

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.

Authors:  Ole Petter Rekvig; Johan Van der Vlag
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

2.  The Functional Requirement for CD69 in Establishment of Resident Memory CD8+ T Cells Varies with Tissue Location.

Authors:  Daniel A Walsh; Henrique Borges da Silva; Lalit K Beura; Changwei Peng; Sara E Hamilton; David Masopust; Stephen C Jameson
Journal:  J Immunol       Date:  2019-06-26       Impact factor: 5.422

3.  Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.

Authors:  Adam J Adler
Journal:  Curr Immunol Rev       Date:  2005-01-01

4.  In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.

Authors:  Marianne A Mihalyo; Amy D H Doody; Jeremy P McAleer; Elizabeth C Nowak; Meixiao Long; Yi Yang; Adam J Adler
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

5.  Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-alpha and IFN-gamma expression potentials.

Authors:  Meixiao Long; Amy D Higgins; Marianne A Mihalyo; Adam J Adler
Journal:  Cell Immunol       Date:  2003-08       Impact factor: 4.868

6.  CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response.

Authors:  António Peixoto; César Evaristo; Ivana Munitic; Marta Monteiro; Alain Charbit; Benedita Rocha; Henrique Veiga-Fernandes
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

7.  Molecular mimicry, inflammatory bowel disease, and the vaccine safety debate.

Authors:  Susy Yusung; Jonathan Braun
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.